Cargando…
Direct Reprogramming to Human Induced Neuronal Progenitors from Fibroblasts of Familial and Sporadic Parkinson’s Disease Patients
In Parkinson’s disease (PD) research, human neuroblastoma and immortalized neural cell lines have been widely used as in vitro models. The advancement in the field of reprogramming technology has provided tools for generating patient-specific induced pluripotent stem cells (hiPSCs) as well as human...
Autores principales: | Lee, Minhyung, Sim, Hyuna, Ahn, Hyunjun, Ha, Jeongmin, Baek, Aruem, Jeon, Young-Joo, Son, Mi-Young, Kim, Janghwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Stem Cell Research
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881039/ https://www.ncbi.nlm.nih.gov/pubmed/31474031 http://dx.doi.org/10.15283/ijsc19075 |
Ejemplares similares
-
Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease
por: Lee, Joo-Eun, et al.
Publicado: (2020) -
Efficient exogenous DNA-free reprogramming with suicide gene vectors
por: Lee, Minhyung, et al.
Publicado: (2019) -
Iroquois Homeobox Protein 2 Identified as a Potential Biomarker for Parkinson’s Disease
por: Sim, Hyuna, et al.
Publicado: (2020) -
Quantitative Proteomic Analysis of Primitive Neural Stem Cells from LRRK2 G2019S-Associated Parkinson’s Disease Patient-Derived iPSCs
por: Sim, Hyuna, et al.
Publicado: (2020) -
Intermediate cells of in vitro cellular reprogramming and in vivo tissue regeneration require desmoplakin
por: Ha, Jeongmin, et al.
Publicado: (2022)